For patients with spinal cord injury and stroke (stroke), standing and walking seem to be an elusive dream, and the birth of an exoskeleton robot will make this dream a reality. So-called exoskeleton robots are popularly known as “outside the human body†robots. They are based on bionics and ergonomic designs. They are also called “wearable robots.†The hard outer parts of the exoskeleton provide support and protection for the human body. The role is mainly for physically handicapped patients and helps them to achieve basic functions such as sitting, standing, walking, and going up and down the stairs. In the medical field, Israel's Rewalk and the United States' EKSO have all obtained FDA certification and entered the stage of marketing. China also has capital, listed companies and start-up companies involved in this area, but at present there is no one company has obtained CFDA certification, and therefore there is no real product into commercial use. On November 11th, Shenzhen Step Robot Technology Co., Ltd. released its first exoskeleton-oriented exoskeleton robot BEARH1. Stepping robot CEO Chen Gong told 21st Century Business Herald reporter that the next step is that their products will enter the clinical trial stage. From the clinical trial to the certification by the food and drug administration department, it may take six months to nine months if the national Innovative medical device access may be shorter. The first flexible joint driver Chen Gong introduced that this launch of the BEARH1 has a dynamic 6-joint (bilateral hip, knee, and ankle), and hip rotation assisted joints, can achieve a natural gait, suitable for height between 150-4750px, weight less than 85Kg The patient uses, and its exoskeleton size is adjustable, and the gait monitoring and evaluation system can be displayed in real time through a touch screen. Through the sensor, the robot can detect the motion state of the human body in real time and predict the human intention through a specific artificial intelligence algorithm. The skeletal level analysis can facilitate doctors to understand the patient's gait and foot condition, further excavate the body function to stimulate the patient's remaining, correct the walking posture, and finally restore normal walking ability. Judging from the technical indicators, the currently available exoskeleton robots on the market mainly use rigid actuators. In contrast, the biggest feature of the new products is the use of flexible actuators as outputs. The advantage is that in the human-machine interaction scene, force feedback is not required without force and torque sensors, which not only improves the stability and accuracy of force control, but also improves safety and saves energy consumption. Founded in September 2016, Move has been the angel investor led by the Lenovo Venture Capital Group this year and has iterated its products to the third generation in more than a year. Liang Ying, executive director of Lenovo Ventures Group, said that not only exoskeleton robots, but also flexible joint drivers will be the key components of many other types of robots in the future. Xu Feng, chairman of Shenzhen Xiang Xiang Biomedical Electronics, also commented that flexible joint technology is currently not seen in the world, which may be the reason why the stepping robot has gone far in this industry. Huge market space According to the national sample survey on handicapped persons, the number of disabled people in our country exceeds 20 million. However, the "Statistical Communique on the Development of China's Persons with Disabilities in 2016" shows that as of 2016, there are 7,858 rehabilitation institutions for disabled people in China, and only 1.357 million people with physical disabilities have received basic rehabilitation services. On the other hand, with the advent of an aging society, the population of cerebrovascular patients is also expanding. The report on the status of nutrition and chronic diseases of Chinese residents (2015) shows that patients with stroke (stroke) in China are increasing at a rate of 9% per year. According to the data of the World Bank, if no more effective measures are taken, by 2030, there will be 31.77 million stroke patients in China. However, traditional medical methods are difficult to deal with the status quo. The number of rehabilitation physiotherapists in China is severely insufficient. According to the number of stroke patients in China, approximately 400,000 rehabilitation physiotherapists are required. However, professional practitioners only have about 20,000, and the gap is huge. After the emergence of exoskeleton robots, assisted medical rehabilitation will benefit more physically disabled people. At the same time, according to industry insiders, the market will reach 100 billion yuan capacity in the future. However, high prices will be a huge obstacle facing ordinary users. At present, the average price of an exoskeleton robot, including US and Israeli products, is between 60-100 million yuan. The founding team of the stepping robot is mainly Dr. Haigui. Chen Gong told reporters of the 21st Century Business Herald. After returning home, he inspected several cities and chose Shenzhen in the end. One of the important reasons is to look at the industrial chain supporting and manufacturing capabilities here. Because of the cost advantages in R&D, manufacturing, etc., their product pricing is expected to be about half that of foreign products in the future. But this is still a higher price. Xu Feng said that although the Chinese market is very large, the biggest problem is that such products are still not supported by medical insurance. Xu Feng also held cautious optimism on the one hand. In 2011, the Health and Development Planning Commission and other relevant departments incorporated nine medical rehabilitation projects into the basic medical insurance payment scope; in 2016, it further increased 20 rehabilitation projects. Chetak Gensets,Diesel Generator,Portable Generator Silent,High Output Dc Generator Wuxi Doton Power , https://www.dotonpower.com